
About FluidForm Bio
FluidForm Bio is a Healthcare company based in Waltham (United States) founded in 2017 by Michael Graffeo and Adam Feinberg. 3D bioprinting solutions for engineered tissues are developed. It operates in the Healthcare and Technology sectors. The company has 19 employees. Its chief executive, as recorded, is Michael Graffeo. FluidForm Bio offers products and services including FRESH 3D Bioprinting. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Drug Discovery. Its legal entity is FLUIDFORM, INC. Its competitors include Amyris, AskBio and Ginkgo Bioworks; 3 of its 3 listed competitors have raised funding.
Company details
FluidForm Bio was founded in 2017 and is based in Waltham, United States. 3D bioprinting solutions for engineered tissues are developed by the company within the biotechnology sector. FRESH technology is integrated with 3D printing, computational biology, synthetic biology, artificial intelligence, and advanced materials. Tissues are constructed using cells and proteins for applications in research and medical fields.
- Headquarters Waltham, United States
- Employees 19
- Founders Michael Graffeo, Adam Feinberg
- SectorsHealthcareTechnology
- Emailβ’β’β’β’β’β’β’β’
- Website fluidformbio.com
- Social LinkedIn X
- Legal Name Fluidform, Inc.
- Latest Funding Round$228.55K (USD), Grant
Aug 2021
- Investors
- Employee Count19
Products & Services of FluidForm Bio
FluidForm Bio offers a comprehensive portfolio of products and services, including FRESH 3D Bioprinting.
Creates vascularized implantable tissues for medical treatments like diabetes.
Funding Insights of FluidForm Bio
- Total Rounds 3
- Last Round Grant β $228,550
- First Round $255,369
(Apr 2021)
- Investors Count 1
All 3 funding rounds of FluidForm Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in FluidForm Bio
FluidForm Bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for FluidForm Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of FluidForm Bio
7 people are tracked at FluidForm Bio (5 in leadership, 2 in team); the tracked headcount is 19.
| Name | Role | Group |
|---|---|---|
Michael Graffeo | Co-Founder & CEO | Leadership |
Adam Feinberg | Co-Founder & CTO | Leadership |
Mike Graffeo | CEO | Leadership |
Rickey Kallicharan | Chief Business Officer | Leadership |
Erik Waters | Chief Financial Officer | Leadership |
Jonathan Paris | Advisor | Team |
Katelynn Russ | Sr. Biomedical Engineer | Team |
Complete people profiles for FluidForm Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of FluidForm Bio
3 dated milestones of FluidForm Bio across 4 years, from founding to its latest funding, stage changes and deals.
- Founded FluidForm Bio is founded.
- Funding First funding round of $255K.
- Funding Latest funding round, Grant, of $229K.
Competitors of FluidForm Bio
FluidForm Bio has 3 listed competitors in our database, 3 of them funded. They include Amyris, AskBio and Ginkgo Bioworks.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amyris.com | 2003 | Emeryville, United States | $487.2M | 747 | Developer of renewable products for industrial solutions | |
| askbio.com | 2001 | Durham, United States | $235M | Gene and protein therapies are developed for treating various diseases. | ||
| ginkgobioworks.com | 2008 | Boston, United States | $795.75M | 1,218 | Gene editing-based cultured ingredients are provided for agriculture. |
Detailed competitors of FluidForm Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of FluidForm Bio
The website of FluidForm Bio (fluidformbio.com) receives about 3K visits a month.
- Monthly visits3K
▲ 74.5% vs previous month
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as FluidForm Bio (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Fluidform Bio
Complete news archive for FluidForm Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FluidForm Bio
FluidForm Bio was founded in 2017 and raised its 1st funding round 4 years after it was founded.
FluidForm Bio is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Michael Graffeo is the CEO of FluidForm Bio, as recorded in our data. They have also founded this company.
FluidForm Bio has 19 employees.
FluidForm Bio was founded in 2017 and is based in Waltham, United States. 3D bioprinting solutions for engineered tissues are developed by the company within the biotechnology sector. FRESH technology is integrated with 3D printing, computational biology, synthetic biology, artificial intelligence, and advanced materials. Tissues are constructed using cells and proteins for applications in research and medical fields.
FluidForm Bio's top competitors include Amyris, AskBio and Ginkgo Bioworks.
FluidForm Bio offers FRESH 3D Bioprinting.
FluidForm Bio has 1 investor. Key investors include HHS.
FluidForm Bio operates through Fluidform, Inc..
